BNP Paribas Financial Markets’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.27K Sell
3,608
-5,971
-62% -$5.42K ﹤0.01% 4191
2025
Q1
$4.33K Sell
9,579
-9,520
-50% -$4.3K ﹤0.01% 4042
2024
Q4
$9.6K Buy
+19,099
New +$9.6K ﹤0.01% 3998
2022
Q4
Sell
-4,209
Closed -$4.76K 3649
2022
Q3
$4.76K Buy
+4,209
New +$4.76K ﹤0.01% 3544
2019
Q3
Sell
-18,017
Closed -$19.8K 3871
2019
Q2
$19.8K Sell
18,017
-7,154
-28% -$7.87K ﹤0.01% 3272
2019
Q1
$33K Buy
25,171
+21,080
+515% +$27.6K ﹤0.01% 3138
2018
Q4
$3.74K Buy
4,091
+103
+3% +$94 ﹤0.01% 3002
2018
Q3
$8.2K Buy
3,988
+60
+2% +$123 ﹤0.01% 3164
2018
Q2
$7.08K Sell
3,928
-19,553
-83% -$35.2K ﹤0.01% 3288
2018
Q1
$55.3K Sell
23,481
-7,394
-24% -$17.4K ﹤0.01% 2935
2017
Q4
$58.1K Buy
30,875
+22,557
+271% +$42.4K ﹤0.01% 2922
2017
Q3
$20.4K Sell
8,318
-1,239
-13% -$3.04K ﹤0.01% 3061
2017
Q2
$26K Buy
9,557
+8,532
+832% +$23.2K ﹤0.01% 3000
2017
Q1
$2.78K Sell
1,025
-470
-31% -$1.28K ﹤0.01% 2885
2016
Q4
$4.4K Sell
1,495
-4,430
-75% -$13K ﹤0.01% 3152
2016
Q3
$19.9K Buy
5,925
+2,965
+100% +$9.95K ﹤0.01% 2892
2016
Q2
$6.52K Buy
2,960
+2,833
+2,231% +$6.24K ﹤0.01% 3133
2016
Q1
$68 Sell
127
-15,143
-99% -$8.11K ﹤0.01% 2632
2015
Q4
$49.9K Sell
15,270
-1,069
-7% -$3.49K ﹤0.01% 2813
2015
Q3
$39.3K Buy
16,339
+10,833
+197% +$26.1K ﹤0.01% 3032
2015
Q2
$15.9K Buy
5,506
+3,877
+238% +$11.2K ﹤0.01% 3192
2015
Q1
$6.21K Buy
1,629
+1,491
+1,080% +$5.68K ﹤0.01% 3026
2014
Q4
$117 Sell
138
-5,630
-98% -$4.77K ﹤0.01% 1940
2014
Q3
$14.6K Buy
+5,768
New +$14.6K ﹤0.01% 2884
2014
Q1
Sell
-593
Closed -$1.72K 3090
2013
Q4
$1.72K Buy
+593
New +$1.72K ﹤0.01% 3199
2013
Q3
Sell
-14,467
Closed -$46.2K 2307
2013
Q2
$46.2K Buy
+14,467
New +$46.2K ﹤0.01% 2358